Our purpose was to determine if there are basal adrenergic influences on the coronary circulation in humans. We studied 56 patients with denervated hearts after cardiac transplantation and 19 normally innervated patients with angiographically normal coronary arteries.
Effects of Regional c-and /3-Blockade on
Resting and Hyperemic Coronary Blood Flow in Conscious, Unstressed Humans John McB. Hodgson, MD, Mark D. Cohen, MD, Szabolcs Szentpetery, MD, and Marc D. Thames, MD Our purpose was to determine if there are basal adrenergic influences on the coronary circulation in humans. We studied 56 patients with denervated hearts after cardiac transplantation and 19 normally innervated patients with angiographically normal coronary arteries.
Coronary blood flow velocity was measured during cardiac catheterization with a subselective 3F intracoronary Doppler catheter. Heart rate was controlled by atrial pacing. Epicardial coronary artery diameter was measured by automated analysis of digital coronary angiograms.
Coronary flow reserve was assessed by intracoronary papaverine hydrochloride (12 mg) injections. Regional sympathetic blockade was produced by intracoronary injections of phentolamine (3 mg, c) and propranolol (2 mg, O) or metoprolol (3 mg, f1). After a-blockade, mean arterial pressure fell significantly (p <0.05) in both the denervated transplant (-5.8±1.5%) (mean±SEM) and normally innervated patients (-12.6±3.2%). Reductions in coronary flow velocity also were observed in these groups (-8.2±2 .3% and -9.2±5.8%, respectively). Calculated coronary vascular resistance was unchanged. Similar changes were seen when patients were pretreated with fj-blockade before a-blockade. Nonspecific fP-blockade did not affect mean arterial pressure but decreased coronary velocity (innervated, -11.6±3.9%O; denervated, -9.3 ±2.4%) and increased coronary vascular resistance (innervated, 15.4±6.7%; denervated, 10.2±3.7%). Coronary vascular resistance did not rise in either group after selective PI1-blockade with metoprolol. Coronary flow reserve did not change in either patient group after either or ,B3blockade. Changes in epicardial coronary artery diameter were small and generally not significant. These data suggest that a-receptor-mediated vascular tone is negligible in both denervated transplant patients and normally innervated patients. Additionally, the increase in vascular resistance after nonselective P-blockade is the result of direct A vascular effects. Our data further suggest that there is little adrenergically mediated epicardial artery tone (either humoral or neural) at rest and that maximal vasodilator responses are not limited by adrenergically mediated vasomotor tone. (Circulation 1989;79:797-809) Adrenergic neural and humoral control of the coronary circulation has been studied extensively in animals1-13 and recently reviewed by Young et al.14 Studies in humans have been hampered by lack of an easily performed and reliable technique for the measurement of coronary blood flow as well as the complex interactions that occur in response to hemodynamic and metabolic in vasomotor tone postulated to produce acute ischemic syndromes in these patients. Thus, we considered it important to determine if there are adrenergic influences on the coronary circulation. These influences may occur in humans either under basal levels of adrenergic influence or during periods of augmented adrenergic stimulation. The studies we report here were designed to investigate the basal influence of neural and humoral adrenergic stimuli in conscious patients. Studies were performed in normally innervated patients and in patients whose coronary arteries and ventricular myocardium were denervated after cardiac transplantation.
The denervated human transplanted heart provides a unique model for studying adrenergic control of the coronary vasculature.32 Denervation eliminates reflex neural mechanisms and allows humoral influences due to circulating catecholamines to be investigated independently from direct neural influences. Additionally, denervation may induce hypersensitivity to circulating catecholamines33 and may, therefore, magnify any adrenergic humoral influences on the coronary circulation.
We addressed three key questions. 1) Is the coronary vasculature tonically influenced by circulating or locally released catecholamines under resting conditions in conscious humans? 2) Is vascular reactivity to maximal hyperemic vasodilator stimuli altered in the denervated state, and to what extent does a-or 83-blockade change peak hyperemic response? 3) Are adrenergic influences active in the epicardial vessels, or are they primarily mediated by smaller intramyocardial resistance vessels?
Methods

Patient Selection
Fifty-six patients were studied after orthotopic cardiac transplantation. All were clinically stable, and none were experiencing acute allograft rejection at the time of the study. The average time from transplant to study was 17 ± 2 months (mean ± SD). Nineteen patients with angiographically normal epicardial coronary arteries and presumed normal coronary innervation served as controls. All were undergoing clinically indicated cardiac catheterization. All patients gave informed consent. The study protocol was approved by the Virginia Commonwealth University Institutional Review Board and by the McGuire Veterans Administration Medical Center Research and Development Committee.
Instrumentation
Data for this protocol were collected during cardiac catheterization with a subselective pulsed Doppler coronary blood flow velocity catheter and automated quantitative analysis of epicardial artery diameter performed on digital angiographic images. All patients underwent routine cardiac catheterization with the Judkins technique. Patients were premedicated with 10 mg diazepam and 50 mg diphen-hydramine orally. All routine medications were continued up to the time of catheterization; however, no additional medications were given during the study protocol. /3-Blockers and arterial vasodilators were held for at least 8 hours before study.
Determination of Coronary Flow Velocity
After routine angiography, a coronary angioplasty guide catheter (Interventional Medical, Danvers, Massachusetts) with an internal lumen of 0.076 in. fitted with a Toughy Borst "Y" adapter (USCI, Billerica, Massachusetts) on its proximal end was advanced to the coronary ostium. A 3F subselective catheter with an end-mounted Doppler crystal (DC-101, Millar Instruments, Houston, Texas) then was advanced into the left anterior descending coronary artery over a 0.012in. guide wire (PDT, Advanced Cardiovascular Systems, Temecula, California). Doppler velocity signals were produced with a 20-MHz pulsed Doppler generator (Baylor College of Medicine, Houston, Texas). Phasic and mean signals proportional to the Doppler frequency shift were recorded with a strip chart recorder. The Doppler catheter was adjusted to obtain the maximum frequency shift with the least artifactual noise with a combination of careful positioning of the catheter within the coronary, an electronic range gate, and an electronic sensitivity filter. The catheter was considered stable when exaggerated inspiration, coughing, and power injections of radiographic contrast through the guide catheter proximal "Y, adaptor failed to alter the basal velocity signal.
Digital Image Acquisition
A radiographic projection that best separated the left anterior descending coronary artery from other structures was selected for all protocol images.
Nonionic, low osmolarity radiographic contrast (Omnipaque 350, Winthrop Breon, New York) was power injected by an electrocardiographically gated injector at rates of 8-12 ml/sec for total volumes of 10-14 ml/injection. Digital images were acquired once per cardiac cycle (end diastole) by a dedicated digital radiographic computer (DPS 4100, ADAC, Milpitas, California) directly interfaced to the radiographic generator (Optimus M200, Phillips, Best, Holland). Images were acquired directly to hard disk in a 512 x 512 x 8 bit matrix after logarithmic analogue-to-digital conversion.
Image processing was performed to allow quantitative automated artery dimension determination by previously validated software. 26 The guiding catheter was used for calibration of absolute size. The arterial diameter was averaged over a length of 1-2 cm without branches. Due to the gated acquisition protocol, all images for each patient were from exactly the same portion of the cardiac cycle (end diastole).
Doppler Catheter Validation
The Doppler catheter has been used before to produce a signal that increases linearly with volume External Crystal Intravascular Catheter Crystal flow. 25 Several experiments were performed in our laboratory to further validate the accuracy of the end-crystal Doppler catheter. First, the Doppler catheter was tested in an in vitro pulsatile flow system with citrated blood perfusate. Flow was determined by a calibrated in-line electromagnetic flow meter (EMF) (Narcomatic, 700-1500, Narco Scientific, Houston, Texas) and varied over a range of 50-450 ml/min. The correlation between changes in Doppler frequency shift and electromagnetic flow was excellent (average correlation, r=0.99; range, 0.98-0.99; n =4). Second, experiments were carried out in four mongrel dogs (25-35 kg) with sodium thiamylal anesthesia (35 mg/kg) and controlled ventilation. An external Doppler crystal of appropriate size (Titronics, Iowa City, Iowa) was fitted to either the left anterior descending or left circumflex coronary arteries. The intravascular Doppler catheter then was advanced to the same portion of the vessel under fluoroscopic control. Simultaneous external and intravascular recordings of velocity then were made during manipulation of flow by vessel occlusion and intracoronary papaverine injection (2-10 mg) via the guiding catheter. Data were analyzed in two ways. The linearity of response between the two Doppler crystals for each animal was evaluated with multiple points and linear regression analysis. The average r value was 0.94 (range, 0.91-0.99). Sample tracings from the two Doppler signals are shown in Figure 1 and demonstrate the similarity in waveforms under widely varying conditions. Changes in coronary velocity were also calculated for each Doppler with both postocclusive reactive hyperemia and papaverine as hyperemic stimuli. The average velocity increase for the external crystal was 2.69 ± 0.65 times resting and for the intravascular catheter, 2.38 ± 0.58 times resting (n = 14). The correlation between external and catheter determinations was good (r= 0.73; catheter = 0.83 external + 0.72; n = 14).
Quantitative Angiography Validation
The digital system and software analysis program (ARTREK, ADAC Laboratories) used have been validated extensively. 26 We performed additional testing with contrast filled arterial phantoms of known size. These phantoms were imaged during patient studies such that they were subject to the same variable background densities as opacified patient coronaries (i.e., ribs, lungs, diaphragm, spine). Quantitative analysis of these phantom images then was performed as if they had been true patient angiograms. The correlation between known phantom size and measured size was excellent (r=0.99, n=8 patients) over the diameter range of 1.5 to 3.75 mm. The average coefficient of variation in measurement for each phantom size between the eight patients was 2.8%. There was no difference in the coefficients of variation among the different size phantoms (1.5-3.75 mm). A separate phantom consisting of serial cylinders varying in diameter by 0.1 mm over the range 2.5-4.0 mm was also imaged. Quantitative analysis of this 0, 
Study Protocol
Thirty-six transplant and 15 normally innervated patients underwent identical protocols (outlined in Figure 2 ). After preblockade measurements of coronary flow velocity, epicardial artery dimension, and coronary flow reserve, patients were randomly assigned to receive either a-blockade (3 mg intracoronary phentolamine) or nonselective 13-blockade (2 mg intracoronary propranolol). After injection, coronary flow velocity was monitored for 2 minutes. Hyperemic measurements then were repeated, and the alternate blocker was administered. Basal flow again was observed for 2 minutes, and finally, a third hyperemic value was obtained. During all measurement periods, heart rate was controlled via right atrial pacing by a 7F Zucker pacing catheter (USCI) that also allowed simultaneous measurement of right atrial pressure. Arterial pressure was monitored via the side port of the 9F femoral sheath through which the 8F guiding catheter was passed. Hyperemic flow was stimulated by intracoronary injection of papaverine hydrochloride: 12 mg if right dominant, and 15 mg if left dominant. These doses produced maximal coronary vasodilatation. Flow reserve was defined as the ratio of peak hyperemic velocity to basal coronary velocity. There were no adverse effects related to papaverine administration.
Seven additional transplant and four additional normally innervated patients underwent an abbreviated protocol with the selective ,13-blocker metoprolol. After preblockade measurements, intracoronary metoprolol (3 mg) was administered, basal flow was monitored, and hyperemia was repeated 2 minutes later.
Thirteen additional patients underwent an abbreviated protocol with injections of saline to establish the effects of vehicle administration (saline control group). After basal measurements, NaCl 0.9% (4 ml) was administered as a bolus through the guide catheter, and velocity was recorded for 2 minutes at which time angiography for diameter determination was repeated.
Eleven patients underwent a longer control observation protocol. Coronary velocity and mean arte-rial pressure were monitored continuously for 10 minutes during saline infusion at 5 ml/min through the guiding catheter (estimated 3% of total left main flow). Epicardial artery diameter was determined before and after the 10-minute infusion.
To ensure that placement of the guiding catheter in the coronary ostium would not alter coronary flow, basal and papaverine-induced hyperemic velocities were recorded with the guide positioned just outside the ostium and again after secure engagement in 16 patients. There was a 2.02±0.11-fold (mean ± SEM) increase in velocity with the catheter outside the ostium and a 2.15 ±0.10-fold increase with the catheter engaged. These values were not significantly different.
The adequacy of a-and 13-blockade was assessed in nine patients. Coronary vascular resistance was calculated at baseline and 15-30 seconds after intracoronary bolus administration of either an aagonist (100-200 ,ug phenylephrine; n = 6)34 or 13agonist (0.5 jig isoproterenol; n = 3).9,35 These measurements then were repeated after intracoronary a-(3 mg phentolamine) or 13-blockade (2 mg propranolol). Data, expressed as percent change from baseline, are shown in Figure 3 and demonstrate that the changes in coronary vascular resistance seen before blockade were abolished by the blocking drugs in the doses used in this study.
After initial femoral sheath placement and before angiography, whole blood was withdrawn for catecholamine determination and placed immediately in a chilled heparinized tube. Plasma was separated by cold centrifugation within 15 minutes of collection, frozen at -75°C, and analyzed subsequently for dopamine, norepinephrine, and epinephrine levels by high-performance liquid chromatography with electrochemical detection (sensitivity, <5 pg/ml). 36 
Calculations and Statistics
Velocity and arterial pressure measurements were evaluated both at 2 minutes after drug injection (LATE) and at the point of maximal velocity change (20-60 seconds) (EARLY).
An index of coronary vascular resistance was calculated as the quotient of mean aortic pressure and velocity. Values expressed as "percent change from baseline" were calculated with the baseline Post Blockade immediately preceding blocker administration, not necessarily the original baseline. Statistics were performed with SAS software (SAS Institute, Cary, North Carolina). Paired t tests were used for comparisons in which each patient served as his own control. Unpaired t tests were used for betweengroup comparisons. Values ofp<0.05 were considered significant. p values of less than 0.10 also are reported as they were taken to indicate trends toward significance. All values are expressed as mean ±1 SEM unless otherwise noted.
Results
Clinical Characteristics
Fifty-six transplant recipients with cardiac denervation and 19 normally innervated patients were studied ( Table 1 ). All were men. The normally All but one normally innervated and six transplant patients had acceptable data for the entire protocol. Right atrial pressure did not change significantly during any portion of the protocol in either patient group.
Saline Control Patients
Bolus injection of saline (n = 13) resulted in only minor changes in arterial pressure, coronary veloc- ity, and coronary vascular resistance index (Table  2) . Epicardial artery size decreased significantly; however, the degree of change was very small (-2.1±0.6%). Ten-minute saline infusion (n =11) produced no significant changes in any parameter at 2 minutes,. with a small (7.9 ±2.4%) increase in resistance after 10 minutes.
Normally Innervated Patients (Table 3 ) (n = 15) a-Blockade. Mean arterial pressure fell significantly after a-blockade. This was associated with a decrease in mean coronary flow velocity but no change in calculated coronary vascular resistance index. Similar results were seen when a-blockade was preceded by P-blockade. There was no significant difference in resistance index response between the P-pretreated and a-only groups, either early or late after blocker administration. Epicardial artery diameter, however, increased after a-blockade alone, but decreased when a-blockade was preceded by p8-blockade. These changes were small (3.9 ± 2.4% and -3.0±1.2%, respectively) but significantly different from each other (p<~0.05).
[3-Blockade. Mean arterial pressure was unchanged after p-blockade. Coronary flow velocity fell and vascular resistance index increased. Epicardial artery diameter was unchanged. Similar changes were 36) a-Blockade. Mean arterial pressure and coronary flow velocity fell significantly after a-blockade without a change in coronary vascular resistance index. Similar changes were seen when a-blockade was preceded by /3-blockade. These changes were more pronounced early after blocker injection and had largely dissipated by the late measurements. Epicardial artery diameter was unchanged by a-blockade.
(-Blockade. Mean arterial pressure was unchanged after /-blockade, whereas coronary flow velocity decreased and vascular resistance index increased. When /3-blockade was preceded by a-blockade, arterial pressure fell slightly, coronary velocity fell to a lesser degree than with /8-blockade alone, and vascular resistance index was unchanged. Epicardial artery diameter increased after /3-blockade, but not when /3-blockade was preceded by a-blockade.
Nornally Innervated Compared with Denervated Transplant Patients
Normally innervated and denervated transplant patients had similar responses to a-blockade both alone and after /3-blockade (Tables 3 and 4, Figure  5 ) with respect to all measured parameters. Likewise, their responses to /3-blockade were similar; however, when /3-blockade was preceded by a-blockade, coronary vascular resistance index rose in the innervated patients but not in the transplant patients (Table 3 and 4, Figure 5 ).
f3l Compared With 2 Effects
To further investigate the alterations in coronary vascular resistance seen after nonselective l3blockade, seven additional transplant and four additional normally innervated patients underwent measurements after selective /,-blockade with metoprolol (Table 5 ) ( Figure 6 ). Resting coronary velocity fell after nonselective blockade but not after selective ,31-blockade. Coronary vascular resistance index increased after nonselective ,3-blockade but was unchanged after selective /,1-blockade. The small increase in epicardial artery diameter seen after nonselective blockade was not seen after selective 3,lblockade. Results were similar for the denervated transplant and normally innervated patient groups.
Coronary Flow Reserve
Coronary flow reserve was unchanged in both the normally innervated and denervated transplant patients after either a-or /3-blockade (Table 6 ).
Discussion
One major finding of this study is that under resting conditions in conscious normally innervated humans, direct a-receptor-mediated neural control of coronary vascular resistance is negligible. The presence or absence of resting adrenergic tone in the coronary vasculature has been the subject of much investigation.14,37 Previous studies in unstressed conscious animals and humans have often yielded conflicting results. Whereas some investigators have reported significant decreases in vascular resistance (or increases in coronary flow) after a-blockade,'0'13'18,23 others have been unable to demonstrate any change.8 '20'38 Our data indicate that significant neurally mediated a-vasoconstrictor tone is not present in resting, unstressed humans.
A second important finding of this study is the demonstration of a significant increase (10-15%) in coronary vascular resistance after /3-blockade in both innervated and denervated patients. This is presumed to be humorally mediated in the latter group as discussed below. Previous studies have been difficult to interpret due to the presence of both vascular and myocardial /-receptors that may alter tone either directly or via physiologic autoregulation. Pitt et al, 9 Bergamaschi et innervated humans with heart rate controlled by pacing. One explanation for this difference between our current findings and those obtained in humans by others20-22 is that our methods (i.e., Doppler velocity catheter) allowed more precise determination of coronary blood flow. Additionally, the administration of /3-antagonist regionally by intracoronary injection and the ability to follow rapid changes in flow velocity may have made it easier to detect small changes. Thus, our data are in general agreement with previous investigations done in conscious animals with heart rate controlled. In these animal studies and our patients, beat-to-beat measures of coronary blood flow were used. Mechanism ofAdrenergic Influence on Coronary Vascular Resistance ,-Receptors. After nonselective P-blockade, there was a significant rise in coronary vascular resis-tance in both the normally innervated and denervated transplant patients ( Figure 5 ). Epicardial vessels were minimally affected by ,B-blockade, thus suggesting that the observed elevations in vascular resistance must have been due to constriction of smaller resistance vessels. One potential explanation for these observations is that resistance increased in response to myocardial 813-receptor inhibition. Because we observed no change in mean aortic pressure and heart rate was controlled, the local metabolic stimulus to constriction in this case would be primary depression of myocardial contractility or reduced wall stress and, thus, reduced myocardial oxygen requirements. Studies in conscious dogs in which determinates of oxygen demand have been measured are in agreement with this theory and suggest a primary role for 131-receptors in regulating the response to 18-blockade.4'6 Our data with the selective 831-blocker metoprolol do not support such an explanation in humans ( Figure   6 ). When P,B-receptors were selectively inhibited, Values are mean±SEM. coronary vascular resistance did not rise significantly. These data suggest that in both denervated transplant and normally innervated patients, there was primary inhibition of vascular 132-receptors that was in large part responsible for the increase in vascular resistance observed after the administration of propranolol. This effect of catecholamines is presumably humorally mediated in the transplant patients, since their hearts are denervated, but may be neurally mediated in normal subjects.
It is possible that the degree of myocardial 831receptor blockade was different for the doses of metoprolol and propranolol used in this study. Because we did not measure myocardial oxygen consumption, we cannot address this issue. Thus, the possibility exists that the lack of increase in vascular resistance following metoprolol was due to inadequate 813-receptor blockade, although we consider this unlikely since both doses were intentionally chosen to be large considering that they were administered directly into the coronary. a-Blockade. Nonselective a-blockade resulted in a significant reduction in mean arterial pressure in both patient groups. There was an associated fall in coronary velocity; however, calculated vascular resistance was not altered significantly (Tables 3 and 4, Figure 5 ).
There may be important effects on the coronary arteries resulting from activation of both prejunc- 10-13'23 The prejunctional effects are thought to regulate norepinephrine release, whereas the postjunctional effects are directly on the vascular smooth muscle. The a-blocker we used, phentolamine, blocks both a1-and a2-receptors. a2-Blockade has been shown to lead to enhanced norepinephrine release, which would be expected to increase the stimulation of ,B-adrenergic receptors in the myocardium and coronary arteries. In our experiments, pretreatment with ,3-blockade before nonselective a-blockade resulted in responses that were similar to those obtained without pretreatment with ,3-blocker. Thus, our data do not support an important role for prejunctional a2-receptors in the regulation of the coronary circulation in conscious, unstressed subjects with normal circulating catecholamines (both groups) and low levels of sympathetic activity to the heart (innervated patients).
Adrenergic influences on maximal coronary flow reserve. Coronary flow reserve has become widely accepted as an indicator of the physiologic significance of pathologic conditions affecting the coronary circulation.39,40 Epicardial stenoses,41,42 myocardial ischemia,43 myocardial hypertrophy,44 and coronary collaterals45 are a few examples of pathologic conditions that decrease coronary flow reserve.
The influence of the autonomic nervous system on coronary flow reserve has been investigated only in animal models. Schwartz and Stone38 have demonstrated a tonic a-mediated vasoconstrictor effect that, when eliminated, resulted in a 30% rise in reactive hyperemia. Additionally, fl-blockade resulted in a 32% fall in reactive hyperemia, possibly due to unopposed a-constriction. This effect of /3blockade was further substantiated by Pauly and Bittar46 who noted a 30-54% fall in total reactive hyperemic volume after transient coronary occlusion.
In contrast to these animal studies, we did not find significant alterations in coronary flow reserve in conscious unstressed humans after adrenergic blockade. It is possible that the flow reserve changes seen in dogs after brief coronary occlusion might have been altered by autonomic blockade via a reduction or augmentation of myocardial ischemia during occlusion. This issue was not addressed by our study. It is apparent from our data, however, that resting autonomic tone does not alter the peak coronary vasodilator response to direct-acting smooth muscle dilators such as papaverine. Different results might have been seen under circumstances of augmented adrenergic stimulation or if a physiologic rather than a pharmacologic stimulus had been used.
Control of epicardial artery diameter. Vatner et al4'6 have shown significant increases in epicardial cross-sectional area after /3-blockade in unstressed animals; however, the exact mechanism for this remains in question.14 We found little effect of either aor fl-blockade on epicardial artery diameter in the unstressed state.
Potential Limitations
Technical factors. It is possible that the quantitative analysis we performed was not accurate enough to pick up small changes. Our protocol, which used electrocardiographically gated images (to ensure they were always obtained at the same portion of the cardiac cycle), precise heart rate control (pacing), identical angiographic projections for each study, diameter averaging over 1-2 cm, and totally operator-independent edge detection, was designed to maximize the accuracy of the technique. Results of our phantom validation studies support the accuracy of analysis. It is likely that any observed changes were biologic rather than errors in the method of measurement and unlikely that significant changes in diameter were not appreciated with this technique.
The expected changes in coronary blood flow in this study were small. One potential limitation of the method used to measure coronary flow might be a lack of sensitivity to small flow changes. The Doppler catheter should, in theory, allow continuous monitoring of true flow changes. In practice, however, multiple variables including movement within the cross-sectional velocity profile, changes in the angle of incidence of the Doppler signal to red blood cells, alterations in the pattern of flow (i.e., laminar versus turbulent), and sensitivity of the crystal can affect the recorded signal. Previously reported measurements in vivo have demonstrated scatter in the Doppler velocity recordings that is not negligible.24 '25 In our validation studies, however, we found excellent agreement between changes in electromagnetically measured flow and Doppler velocity shift. Additionally, our study design was such that only serial measurements were compared, with each patient serving as his own control, thereby increasing the probability of correctly identifying trends of small magnitude. We have found the end-mounted crystal catheter used in this study to be extremely stable in comparison with sidemounted crystal catheters, which tend to be much more position dependent. Thus, it was very rare during our protocol for the catheter to require repositioning despite the multiple hand and power injections of drugs and radiographic contrast. Due to the small changes in velocity expected, we also have chosen to present the velocity data unmodified. Volume flow calculations would require obtaining the product of velocity and arterial crosssectional area. The changes in arterial diameter seen in our study were extremely small (<3%) and thus are unlikely to have influenced the assumed flow alterations observed. Rather, any errors in either the diameter or velocity determinations would have been magnified by calculating volume flow, further reducing our ability to detect small flow changes.
Biologicfactors. Some of our patients (nine transplant and two normally innervated) had been taking ,B-adrenoceptor antagonists for therapeutic reasons before this study. Although the drug was stopped at least 8 hours before the study, there may have been residual pB-blockade that could have confounded the results for patients receiving pl-blockade during the protocol. When analyzed separately, however, patients who had been on clinical p-blocking agents had increases in vascular resistance after protocol administration of pl-blockade similar to those patients who had not been on clinical p-blocking drugs. These data suggest that sufficient washout of the clinically administered p-blocking agent had occurred before the study protocol.
We have assumed that the transplant patients were different from control patients only in that their coronaries would not be influenced by direct neural stimuli. It is possible that the chronic rejection process altered vascular responsiveness in the transplant patients. The effects of adrenergic blockade on resting coronary hemodynamics found in this study, however, were no different in a subgroup of patients an average of 2.7 months (none more than 5 months) after transplantation than in patients an average of 18.6 months (none less than 9 months) after transplant. If chronic transplant rejection was an important modifier of the vascular effects of adrenergic blockade, some difference between these two groups of patients might have been expected. It is possible, however, that even in the early posttransplant period significant vascular changes occur and that the responses to autonomic blockade observed in this study actually represent abnormal responses related to these vascular changes.
Clinical significance. This investigation characterized resting adrenergic influences on the human coronary circulation. Previous studies in patients have suggested that under conditions of heightened adrenergic influence (either neural or humoral) coronary vascular resistance can be markedly increased and that this effect may be exaggerated in the presence of p-blockade.28-31 Our data would support this hypothesis and suggest that even under basal conditions ,-adrenergic influences are not negligible. Furthermore, our data suggest that alterations in vascular tone produced by adrenergic blockade occur primarily at the level of the resistance vessels. It is likely that both transplant patients and patients with coronary heart disease have diffuse endothelial damage. Disruption of the endothelium has been shown to markedly alter vasomotor responses in coronary vessels.47 Thus, abnormal endothelial function in addition to changes in neural tone or circulating catecholamines could result in significant coronary flow alterations in patients with coronary atherosclerosis.
